• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗中性粒细胞胞浆自身抗体(ANCA)相关系统性血管炎患者存在针对ANCA抗原的T淋巴细胞反应,且在疾病缓解期持续存在。

T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.

作者信息

King W J, Brooks C J, Holder R, Hughes P, Adu D, Savage C O

机构信息

Renal Immunobiology, University of Birmingham, UK.

出版信息

Clin Exp Immunol. 1998 Jun;112(3):539-46. doi: 10.1046/j.1365-2249.1998.00615.x.

DOI:10.1046/j.1365-2249.1998.00615.x
PMID:9649227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1904981/
Abstract

ANCA with specificity for myeloperoxidase (MPO) and proteinase 3 (PR3) are present in patients with systemic vasculitis. The aim of this work was to determine whether such patients have T cell responses to these antigens and whether these responses are related to disease activity. Peripheral blood lymphocytes from 45 patients and 19 controls were cultured with ANCA antigens and proliferation measured. The antigens used were heat-inactivated (HI) MPO, HI PR3, native (non-HI) PR3, HI whole alpha-granules, and 25 overlapping peptides covering the entire PR3 sequence. Significant responses to both whole PR3 preparations were seen from patient and control groups, and to the alpha-granules from the patient group. Patients responded at all stages of disease: active, remitting, treated or untreated. Only two patients responded significantly to MPO. Responses were significantly higher with the patient group than the control group to all four whole ANCA antigens. Responses to those PR3 peptides containing epitopes known to be recognized by ANCA were detected from one patient. Thus, these studies demonstrate that T cells from vasculitis patients can proliferate to PR3 and occasionally to associated ANCA antigens. Further, responses may persist even after disease remission has been achieved.

摘要

抗髓过氧化物酶(MPO)和蛋白酶3(PR3)的抗中性粒细胞胞浆抗体(ANCA)存在于系统性血管炎患者中。这项研究的目的是确定此类患者是否对这些抗原有T细胞反应,以及这些反应是否与疾病活动相关。将45例患者和19例对照的外周血淋巴细胞与ANCA抗原一起培养并测量增殖情况。使用的抗原是热灭活(HI)MPO、HI PR3、天然(非HI)PR3、HI全α颗粒,以及覆盖整个PR3序列的25个重叠肽段。患者组和对照组对两种完整PR3制剂均有显著反应,患者组对α颗粒有反应。患者在疾病的所有阶段均有反应:活动期、缓解期、治疗或未治疗。只有两名患者对MPO有显著反应。患者组对所有四种完整ANCA抗原的反应均显著高于对照组。从一名患者中检测到对那些含有已知被ANCA识别的表位的PR3肽段的反应。因此,这些研究表明血管炎患者的T细胞可对PR3以及偶尔对相关ANCA抗原发生增殖反应。此外,即使在疾病缓解后反应仍可能持续。

相似文献

1
T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.抗中性粒细胞胞浆自身抗体(ANCA)相关系统性血管炎患者存在针对ANCA抗原的T淋巴细胞反应,且在疾病缓解期持续存在。
Clin Exp Immunol. 1998 Jun;112(3):539-46. doi: 10.1046/j.1365-2249.1998.00615.x.
2
T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).韦格纳肉芽肿病(WG)患者中T细胞对蛋白酶3和髓过氧化物酶的反应性。
Clin Exp Immunol. 1994 Dec;98(3):448-53. doi: 10.1111/j.1365-2249.1994.tb05511.x.
3
Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.细菌蛋白免疫后抗中性粒细胞胞浆抗体(ANCA)相关的系统性血管炎
Clin Exp Rheumatol. 2002 Nov-Dec;20(6):783-9.
4
In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.抗蛋白酶3和抗髓过氧化物酶相关血管炎患者的T细胞对蛋白酶3和髓过氧化物酶的体外细胞因子产生及增殖情况
Arthritis Rheum. 2002 Jul;46(7):1894-904. doi: 10.1002/art.10384.
5
T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis.系统性血管炎患者对髓过氧化物酶(MPO)和蛋白酶3(PR3)的T细胞反应。
Clin Exp Immunol. 1996 Feb;103(2):253-8. doi: 10.1046/j.1365-2249.1996.d01-629.x.
6
IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.与来自蛋白酶3-抗中性粒细胞胞浆抗体阳性患者的IgG相比,来自髓过氧化物酶-抗中性粒细胞胞浆抗体阳性患者的IgG能刺激致敏中性粒细胞产生更强的激活作用。
Arthritis Rheum. 2001 Apr;44(4):921-30. doi: 10.1002/1529-0131(200104)44:4<921::AID-ANR149>3.0.CO;2-4.
7
B cell epitope specificity in ANCA-associated vasculitis: does it matter?抗中性粒细胞胞浆抗体相关性血管炎中的B细胞表位特异性:重要吗?
Clin Exp Immunol. 2004 Sep;137(3):451-9. doi: 10.1111/j.1365-2249.2004.02572.x.
8
Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.缓解期抗中性粒细胞胞浆自身抗体相关性系统性血管炎患者循环中蛋白酶3水平升高。
Clin Exp Immunol. 2003 Mar;131(3):528-35. doi: 10.1046/j.1365-2249.2003.02083.x.
9
Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils.通过使中性粒细胞暴露于脱颗粒自体中性粒细胞的上清液来诱导其对髓过氧化物酶抗体的反应性。
Blood. 2000 Oct 15;96(8):2822-7.
10
Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.中国临床疑似血管炎患者抗中性粒细胞胞浆抗体的检出率及抗原特异性
Clin Diagn Lab Immunol. 2004 May;11(3):559-62. doi: 10.1128/CDLI.11.3.559-562.2004.

引用本文的文献

1
The evolving landscape of vasculitis management: past, current and emerging.血管炎治疗的演变历程:过去、现在与未来
Rheumatology (Oxford). 2025 Mar 1;64(Supplement_1):i2-i10. doi: 10.1093/rheumatology/keae613.
2
New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis.抗中性粒细胞胞浆抗体相关性血管炎的新型治疗靶点新见解。
Front Immunol. 2021 Apr 1;12:631055. doi: 10.3389/fimmu.2021.631055. eCollection 2021.
3
Conformational changes in myeloperoxidase induced by ubiquitin and NETs containing free ISG15 from systemic lupus erythematosus patients promote a pro-inflammatory cytokine response in CD4 T cells.泛素和来自系统性红斑狼疮患者的含有游离ISG15的中性粒细胞胞外陷阱诱导的髓过氧化物酶构象变化促进CD4 T细胞中的促炎细胞因子反应。
J Transl Med. 2020 Nov 11;18(1):429. doi: 10.1186/s12967-020-02604-5.
4
Cytokines: Names and Numbers You Should Care About.细胞因子:你应该了解的名称和编号。
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2243-54. doi: 10.2215/CJN.07590714. Epub 2015 May 4.
5
The immunopathology of ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎的免疫病理学
Semin Immunopathol. 2014 Jul;36(4):461-78. doi: 10.1007/s00281-014-0436-6. Epub 2014 Jul 24.
6
Analysis of T-cell receptor usage in myeloperoxidase--antineutrophil cytoplasmic antibody-associated renal vasculitis.髓过氧化物酶-抗中性粒细胞胞质抗体相关性肾血管炎中 T 细胞受体使用的分析。
Clin Exp Nephrol. 2010 Feb;14(1):36-42. doi: 10.1007/s10157-009-0230-2. Epub 2009 Oct 7.
7
ANCA patients have T cells responsive to complementary PR-3 antigen.抗中性粒细胞胞浆抗体(ANCA)患者具有对互补性蛋白酶3(PR-3)抗原产生反应的T细胞。
Kidney Int. 2008 Nov;74(9):1159-69. doi: 10.1038/ki.2008.309. Epub 2008 Jul 2.
8
Imatinib mesylate, a new kid on the block for the treatment of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis?甲磺酸伊马替尼,治疗抗中性粒细胞胞浆自身抗体相关血管炎的新成员?
Clin Exp Immunol. 2008 Mar;151(3):391-8. doi: 10.1111/j.1365-2249.2007.03572.x. Epub 2008 Jan 10.
9
Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.失衡:抗中性粒细胞胞浆抗体(ANCA)相关血管炎中的T细胞
Clin Exp Immunol. 2005 Aug;141(2):201-10. doi: 10.1111/j.1365-2249.2005.02808.x.
10
Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关血管炎中CD4 T细胞亚群的异常
Clin Exp Immunol. 2005 Apr;140(1):181-91. doi: 10.1111/j.1365-2249.2005.02731.x.

本文引用的文献

1
Primary systemic vasculitis.原发性系统性血管炎
Lancet. 1997 Feb 22;349(9051):553-8. doi: 10.1016/s0140-6736(97)80118-3.
2
Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase.中性粒细胞丝氨酸蛋白酶3和弹性蛋白酶诱导的内皮细胞凋亡。
Am J Pathol. 1996 Nov;149(5):1617-26.
3
T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis.系统性血管炎患者对髓过氧化物酶(MPO)和蛋白酶3(PR3)的T细胞反应。
Clin Exp Immunol. 1996 Feb;103(2):253-8. doi: 10.1046/j.1365-2249.1996.d01-629.x.
4
Serum markers of T cell activation in relapses of Wegener's granulomatosis.韦格纳肉芽肿复发时T细胞活化的血清标志物
Clin Exp Immunol. 1993 Mar;91(3):415-20. doi: 10.1111/j.1365-2249.1993.tb05918.x.
5
Cyclosporin A therapy for Wegener's granulomatosis.环孢素A治疗韦格纳肉芽肿病
Adv Exp Med Biol. 1993;336:473-6. doi: 10.1007/978-1-4757-9182-2_85.
6
IgG subclass distribution and complement activation ability of autoantibodies to neutrophil cytoplasmic antigens (ANCA).抗中性粒细胞胞浆抗原(ANCA)自身抗体的IgG亚类分布及补体激活能力
Clin Immunol Immunopathol. 1994 Jan;70(1):32-9. doi: 10.1006/clin.1994.1007.
7
Nomenclature of systemic vasculitides. Proposal of an international consensus conference.系统性血管炎的命名法。国际共识会议提案。
Arthritis Rheum. 1994 Feb;37(2):187-92. doi: 10.1002/art.1780370206.
8
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.单克隆抗体疗法使难治性系统性血管炎长期缓解。
Lancet. 1993 Jun 26;341(8861):1620-2. doi: 10.1016/0140-6736(93)90759-a.
9
T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).韦格纳肉芽肿病(WG)患者中T细胞对蛋白酶3和髓过氧化物酶的反应性。
Clin Exp Immunol. 1994 Dec;98(3):448-53. doi: 10.1111/j.1365-2249.1994.tb05511.x.
10
Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.血浆中蛋白酶3及其与α1-蛋白酶抑制剂和抗中性粒细胞胞浆抗体(ANCA)复合物的检测。
J Immunol Methods. 1994 Oct 14;175(2):215-25. doi: 10.1016/0022-1759(94)90364-6.